Sichuan Kelun-Biotech Biopharmaceutical Gets NMPA's Nod Marketing Approval for Breast Cancer Drug; Share Up 5%
Sichuan Kelun-Biotech Biopharmaceutical Gets NMPA's Nod Marketing Approval for Breast Cancer Drug; Share Up 5%
四川科伦药业生物制药获得NMPA批准乳腺癌药物上市许可；股价上涨5%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间